GNAS 抗体 (N-Term)
Quick Overview for GNAS 抗体 (N-Term) (ABIN630216)
抗原
See all GNAS 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
特异性
- GNAS antibody was raised against the N terminal of GNAS
-
纯化方法
- Purified
-
免疫原
- GNAS antibody was raised using the N terminal of GNAS corresponding to a region with amino acids NPENQFRVDYILSVMNVPDFDFPPEFYEHAKALWEDEGVRACYERSNEYQ
-
-
-
-
应用备注
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
GNAS Blocking Peptide, (ABIN5613807), is also available for use as a blocking control in assays to test for specificity of this GNAS antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of GNAS antibody in PBS
-
浓度
- Lot specific
-
缓冲液
- PBS
-
注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- GNAS (GNAS Complex Locus (GNAS))
-
别名
- GNAS
-
背景
- Mutations in GNAS gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors.
-
分子量
- 46 kDa (MW of target protein)
-
途径
- Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, Embryonic Body Morphogenesis
抗原
-